Karst Peak Capital’s Taiwan Liposome Company, Ltd. American Depository Shares TLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-568,965
Closed -$2.1M 4
2020
Q1
$2.1M Hold
568,965
3.16% 3
2019
Q4
$3.06M Hold
568,965
2.57% 4
2019
Q3
$2.96M Hold
568,965
3.63% 4
2019
Q2
$3.02M Hold
568,965
4.17% 3
2019
Q1
$3.32M Hold
568,965
8.01% 2
2018
Q4
$3.13M Buy
+568,965
New +$3.38M 11.49% 3

Other funds holding TLC

Karst Peak Capital's TLC Position: Q2 2020 in Review

Karst Peak Capital sold out of Taiwan Liposome Company, Ltd. American Depository Shares (TLC) in Q2 2020, closing a stake of 568,965 shares — an estimated $2.1M sold.

Karst Peak Capital first reported a position in TLC in Q4 2018 and held it in 6 quarters. The position peaked at $3.32M in Q1 2019. 6 funds tracked by Wall St. Rank hold TLC as of Q2 2020.

  • Karst Peak Capital reported no remaining Taiwan Liposome Company, Ltd. American Depository Shares position as of Q2 2020 after selling out during the quarter.
  • Karst Peak Capital sold 568,965 Taiwan Liposome Company, Ltd. American Depository Shares shares in Q2 2020, an estimated $2.1M.
  • Karst Peak Capital first reported a position in Taiwan Liposome Company, Ltd. American Depository Shares in Q4 2018 and held it in 6 quarters.
  • Karst Peak Capital's Taiwan Liposome Company, Ltd. American Depository Shares position peaked at $3.32M in Q1 2019.
  • 6 funds tracked by Wall St. Rank held Taiwan Liposome Company, Ltd. American Depository Shares as of Q2 2020.

Based on Karst Peak Capital's 13F filing for Q2 2020, filed 14 Aug 2020.